Sodium Chloride Injection Bags Recalled for Potential Leakage and Sterility Risk
B. Braun Medical Inc. is recalling 79,880 bags of Sodium Chloride Injection due to potential leakage that could compromise sterility. No illnesses or injuries have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of an intravenous drug with potential for sterility compromise due to leakage. Although contamination of IV solutions could cause serious harm, no illnesses or injuries have been reported, limiting the score to High per the rubric's criterion for risk-of-harm products without reported injury.
Plain-English summary
B. Braun Medical Inc. is recalling 79,880 bags of 0.9% Sodium Chloride Injection USP in 1000 mL Excel Plus Containers. The product was distributed nationwide in the United States. The affected lots are 0061858305 and 0061858306, with an expiration date of March 31, 2025.
The recall was issued because bags have the potential to leak, which compromises the sterility assurance of the product. Sodium Chloride Injection is a sterile solution intended for intravenous use.
No illnesses or injuries have been reported in connection with this recall.
The recalled product
- Product
- SODIUM CHLORIDE (SODIUM CHLORIDE)
- Brand
- SODIUM CHLORIDE
- Manufacturer
- B. Braun Medical Inc.
- Category
- Drug — Intravenous Solution
- Hazard
- leakage
- sterility-breach
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: 0061858305
- 0061858306 Exp 3/31/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · SODIUM CHLORIDE
- HighInjectable Sodium Chloride Ampules Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-04-22
- HighInjectable Sodium Chloride Recalled Due to Sterility Assurance Issue
FDA (Drugs) · 2026-04-15
- HighInjectable Sodium Chloride Recall Due to Sterility Assurance Issue
FDA (Drugs) · 2026-04-15
- HighSodium chloride intravenous injection recalled for lack of sterility assurance
FDA (Drugs) · 2026-04-15
- HighSodium Chloride IV Injection Recall for Sterility Assurance Concerns
FDA (Drugs) · 2026-04-15
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27